by Natasha Tracy • September 22, 2025
In 2025, the fight against high “bad” cholesterol (LDL) has gained a potent new arsenal. Beyond high-intensity statins, injectable PCSK9 inhibitors, like evolocumab (Repatha) and alirocumab (Praluent), and the siRNA therapy inclisiran (Leqvio)....
Whats Trending
by Natasha Tracy • September 8, 2025
Ozempic face—the hollow-cheeked, suddenly-sagging look that can follow rapid weight loss on semaglutide...
Whats Trending